Litcius/Paper detail

Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk

Goran Koraćević, Milovan Stojanović, Dragan Lović, Marija Zdravković, Dejan Sakač

2021Journal of Human Hypertension15 citationsDOI

Topics & Concepts

MedicineLeft ventricular hypertrophyCardiologyBisoprololInternal medicineVentricular fibrillationHeart failureBlood pressureBlood Pressure and Hypertension StudiesCardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Litcius